Amneal Pharmaceuticals, Inc. 4

Executive Vice President Nikita Shah sold 146,403 shares of Amneal Pharmaceuticals, Inc. Class A Common Stock for about $2.57 million and now holds 253,390 shares.

On August 12, 2026, Executive Vice President Nikita Shah of Amneal Pharmaceuticals, Inc. sold 146,403 shares of the company’s Class A Common Stock in an open-market transaction at a weighted average price of $17.51 per share, with individual sale prices ranging from $17.40 to $17.67. The aggregate transaction value was approximately $2.57 million, and following this disposition Ms. Shah reported direct ownership of 253,390 shares of Amneal Class A Common Stock. The sale appears to be a significant insider disposition given its multi-million dollar size, though it leaves the insider with a substantial remaining equity stake in the company.

Filing Facts

CIK

1723128

Ticker

AMRX

Form

4

Source Type

fda

Accession

0001628280-26-056757

Alert Tier

7